National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 45909 [2023-15094]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 136 / Tuesday, July 18, 2023 / Notices
PaperworkReductionActof1995/PRAListing.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
FOR FURTHER INFORMATION CONTACT:
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–576 and CMS–
576A]
Agency Information Collection
Activities: Proposed Collection;
Extension of Comment Period
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Agency information collection
activities: Proposed collection; comment
request; extension of comment period.
AGENCY:
This notice extends the
comment period for a 60-day notice
request for proposed information
collection request associated with the
notice [Document Identifier: CMS–576
and CMS–576A] entitled ‘‘Organ
Procurement Organization (OPO)
Request for Designation as an OPO,
Health Insurance Benefits Agreement,
and Supporting Regulations’’ that was
published in the June 13, 2023 Federal
Register. The comment period for the
information collection request, which
would have ended on August 14, 2023,
is extended to August 28, 2023.
DATES: The comment period for the
information collection request
published in the June 13, 2023, Federal
Register (88 FR 38513) is extended to
August 24, 2023.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number l, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:16 Jul 17, 2023
Jkt 259001
William N. Parham at (410) 786–4669.
In the FR
Doc. 2023–12535 of June 13, 2023 (88
FR 38513), we published a Paperwork
Reduction Act notice requesting a 60day public comment period for the
document entitled ‘‘Organ Procurement
Organization (OPO) Request for
Designation as an OPO, Health
Insurance Benefits Agreement, and
Supporting Regulations.’’ There were
technical delays associated with making
the information collection request
publicly available; therefore, in this
notice we are extending the comment
period from the date originally listed in
the June 13, 2023, notice.
SUPPLEMENTARY INFORMATION:
Dated: July 13, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2023–15188 Filed 7–17–23; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group Acquired Immunodeficiency
Syndrome Research Study Section Acquired
Immunodeficiency Syndrome Research
Study Section (AIDS).
Date: August 9–10, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G21B,
Rockville, MD 20892 (Zoom meeting).
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
45909
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G21B, Bethesda, MD
20852, (240) 669–5035, robert.unfer@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 12, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–15094 Filed 7–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Bureau of Indian Affairs
[234A2100DD/AAKC001030/
A0A501010.999900]
Indian Gaming; Approval by Operation
of Law of Amendment to Class III
Tribal-State Gaming Compact (Prairie
Band Potawatomi Nation and State of
Kansas)
Bureau of Indian Affairs,
Interior.
ACTION: Notice.
AGENCY:
This notice publishes the
approval by operation of law of an
amendment to the Tribal-State Gaming
Compact for Regulation of Class III
Gaming between the Prairie Band
Potawatomi Nation and State of Kansas
(Compact) governing class III gaming for
the Prairie Band Potawatomi Nation
(Nation) in the State of Kansas (State).
DATES: The amendment takes effect on
July 18, 2023.
FOR FURTHER INFORMATION CONTACT: Ms.
Paula L. Hart, Director, Office of Indian
Gaming, Office of the Assistant
Secretary—Indian Affairs, Washington,
DC 20240, (202) 219–4066.
SUPPLEMENTARY INFORMATION: The
Indian Gaming Regulatory Act of 1988,
25 U.S.C. 2701 et seq., (IGRA) provides
the Secretary of the Interior (Secretary)
with 45 days to review and approve or
disapprove a Tribal-State compact
governing the conduct of class III
gaming activity on the Tribe’s Indian
lands. 25 U.S.C. 2710(d)(8). If the
Secretary does not approve or
disapprove a Tribal-State compact
within the 45 days, IGRA provides that
the Tribal-State compact is considered
to have been approved by the Secretary
but only to the extent the compact is
consistent with IGRA. 25 U.S.C.
2710(d)(8)(c). The IGRA also requires
SUMMARY:
E:\FR\FM\18JYN1.SGM
18JYN1
]]>Agencies
[Federal Register Volume 88, Number 136 (Tuesday, July 18, 2023)]
[Notices]
[Page 45909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15094]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group Acquired Immunodeficiency Syndrome Research
Study Section Acquired Immunodeficiency Syndrome Research Study
Section (AIDS).
Date: August 9-10, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G21B,
Rockville, MD 20892 (Zoom meeting).
Contact Person: Robert C. Unfer, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G21B,
Bethesda, MD 20852, (240) 669-5035, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 12, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-15094 Filed 7-17-23; 8:45 am]
BILLING CODE 4140-01-P
